| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Current Ratio | 219 | % | +41.9% |
| Debt-to-equity | 75.5 | % | -47.3% |
| Return On Equity | -268 | % | +53.2% |
| Return On Assets | -153 | % | +35.1% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 1.75M | shares | -97.8% |
| Entity Public Float | 1.72B | USD | +14886% |
| Common Stock, Value, Issued | 2K | USD | 0% |
| Weighted Average Number of Shares Outstanding, Basic | 1.59M | shares | +3137% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 1.06M | USD | -86.8% |
| General and Administrative Expense | 6.64M | USD | +29.9% |
| Nonoperating Income (Expense) | 179K | USD | +84.5% |
| Net Income (Loss) Attributable to Parent | -7.52M | USD | +42.2% |
| Earnings Per Share, Basic | 62.2 | USD/shares | +97.9% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 3.02M | USD | +1298% |
| Assets, Current | 3.48M | USD | +345% |
| Property, Plant and Equipment, Net | 657K | USD | -5.33% |
| Assets | 4.14M | USD | +180% |
| Accounts Payable, Current | 1.87M | USD | |
| Accrued Liabilities, Current | 336K | USD | |
| Liabilities, Current | 2.26M | USD | -32.3% |
| Liabilities | 2.45M | USD | -30.2% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | 21K | USD | 0% |
| Retained Earnings (Accumulated Deficit) | -162M | USD | -4.88% |
| Stockholders' Equity Attributable to Parent | 1.7M | USD | |
| Liabilities and Equity | 4.14M | USD | +180% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -1.89M | USD | -43.4% |
| Net Cash Provided by (Used in) Financing Activities | -2M | USD | -205% |
| Common Stock, Shares Authorized | 75M | shares | 0% |
| Common Stock, Shares, Issued | 1.59M | shares | -8.94% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -1.89M | USD | -43.2% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 3.02M | USD | +1298% |
| Deferred Tax Assets, Valuation Allowance | 31.3M | USD | -3.16% |
| Deferred Tax Assets, Gross | 31.3M | USD | -3.16% |
| Depreciation | 17K | USD | +13.3% |
| Deferred Tax Assets, Operating Loss Carryforwards | 27.9M | USD | -4.43% |
| Preferred Stock, Shares Authorized | 5M | shares | 0% |
| Share-based Payment Arrangement, Expense | 545K | USD | -51.9% |
| Preferred Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |